Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
A 2025 intravenous safety study involving two healthy adults found infusions up to 20 mg well tolerated, with no adverse events or clinically meaningful changes in vital signs or laboratory biomarkers
View Protocol Complete dosage protocol and reconstitution guide for GHK-Cu (100 mg Vial)
Phase 2 Clinical Trial Data The landmark Phase 2 trial of retatrutide in obesity was a 48-week, randomized, double-blind, placebo-controlled study published in The New England Journal of Medicine in 2023
Growth hormone may produce greater total body composition changes due to simultaneous fat loss and muscle gain, but for individuals seeking pure fat reduction, AOD-9604 s targeted approach can be equally or more appropriate
5 Amino 1MQ 50mg Out of stock 5-Amino-1-methylquinolinium (5-Amino-1MQ) is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT) that has attracted research interest for its role in cellular metabolism, NAD+ salvage, and adipogenesis pathways
Do not use these codes for dates of service on or after January 1, 2013
US$ 22.25
US$ 20.41
US$ 29.77
US$ 20.65
